Erythema multiforme-like eruptions due to topical medications: Part II.
D001453:Balsams / Q000009:adverse effects; D002701:Chloramphenicol / Q000008:administration & dosage / Q000009:adverse effects; D007464:Clioquinol / Q000008:administration & dosage / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology*; D004464:Econazole / Q000008:administration & dosage / Q000009:adverse effects; D004892:Erythema Multiforme / Q000139:chemically induced*; D005029:Ethylenediamines / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005664:Furazolidone / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008272:Mafenide / Q000008:administration & dosage / Q000009:adverse effects; D008615:Mephenesin / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D009355:Neomycin / Q000008:administration & dosage / Q000009:adverse effects; D009581:Nitrofurans / Q000008:administration & dosage / Q000009:adverse effects; D009824:Ointments / Q000009:adverse effects*; D011398:Promethazine / Q000008:administration & dosage / Q000009:adverse effects; D012601:Scopolamine / Q000008:administration & dosage / Q000009:adverse effects; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects; D014810:Vitamin E / Q000008:administration & dosage / Q000009:adverse effects
D001453:Balsams; D005029:Ethylenediamines; D009581:Nitrofurans; D009824:Ointments; D013449:Sulfonamides; D014810:Vitamin E; D008272:Mafenide; D005664:Furazolidone; C031234:ethylenediamine; D002701:Chloramphenicol; D004464:Econazole; D008615:Mephenesin; D007464:Clioquinol; D012601:Scopolamine; D011398:Promethazine; D009355:Neomycin